Dr. Richard Larson's Model-Based Thinking Solves Everyday Problems
Contributor
Hear this story
For more than five decades, Richard Larson, PhD, has shaped the field of operations research with a deep commitment to solving real-world problems. Since 1969, he has worked as a professor at the Massachusetts Institute of Technology (MIT). Though he is now retired, Dr. Larson's expertise has influenced urban emergency response systems, educational innovation and model-based thinking.
An Invitation to Greatness
The power of mathematics and analytics is the central focus of Dr. Larson's influential career. The field of operations research has broad applications, and throughout his career, he has served as a bridge between mathematics and practical problem-solving. The work he's done has impacted public policy and improved decision-making processes.
Dr. Larson found inspiration in the mentorship of professor Al Drake, who invited him to attend MIT. The guidance he received led to a 54-year tenure at the prestigious institution. As a professor, he applied advanced theoretical knowledge in ways that impact cities and institutions worldwide.
A Mathematical Model That Saves Lives
Dr. Larson co-founded an applied research and consulting firm known over the years as ENFORTH Corporation and Q.E.D. The firm aims to share its work beyond the halls of academia. This endeavor reflects his focus on the practical implementation of ideas, as he believes research should contribute to tangible improvements in society.
Dr. Larson's Hypercube Queuing Model, a sophisticated mathematical framework that optimizes emergency response systems, exemplifies this improvement mindset. This model improved how police, fire and medical services allocate resources. A key outcome of this project was faster response times in critical situations.
A Champion for Open-Access Education
A passion for education is an integral part of Dr. Larson's career. As a co-founder of MIT BLOSSOMS (Blended Learning Open-Source Science Or Math Studies), he seeks to make science and mathematics more accessible. This initiative, created alongside MIT professor Dan Frey and his late wife, Mary Elizabeth Murray, offers students worldwide free science and math video lessons. The program is one of the earliest large-scale open-source learning repositories and is available on YouTube.
Dr. Larson has also been president of the Operations Research Society of America (ORSA) and the Institute for Operations Research and Management Sciences (INFORMS). These leadership roles embody his dedication to knowledge sharing within the industry.
A Better Way to Make Decisions
INFORMS published Dr. Larson's latest work, 'Model Thinking for Everyday Life," in 2023. This reader-friendly book encapsulates his lifelong interest in analytical reasoning. The guide is a resource on how structured thinking models benefit everyday decisions. Readers can use the information to refine their decision-making skills.
Dr. Larson hopes to change how people approach personal and professional problem-solving. As he sees it, model-based thinking can lead to better business, government or daily life choices.
Looking Ahead to Impact More Lives
Even after retirement, Dr. Larson continues his involvement with the National Academy of Engineering and supports various charitable initiatives. At some point, he plans on expanding the reach of his book onto other platforms, such as Barnes & Noble. He aims to promote the adoption of mathematical models in everyday decision-making.
For those aspiring to enter operations research or related fields, Dr. Larson advises staying open to new ideas and incorporating personal experiences into one's work. This acumen has helped him make life-changing contributions to emergency response optimization, open-access education and model-based thinking. Applying mathematical rigor to real-world problems solidifies his influence beyond academia.
About Marquis Who's Who®: Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field, including politics, business, medicine, law, education, art, religion and entertainment. Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms worldwide. The suite of Marquis® publications can be viewed at the official Marquis Who's Who® website, www.marquiswhoswho.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
MIT Student Drops Out Because She Says AGI Will Kill Everyone Before She Can Graduate
We're all probably feeling a little anxious about AI. It's horrible for the environment, is used as an excuse to fire workers, floods the internet with misinformation and slop, entrenches government surveillance, and appears to be driving people into psychosis. And so, at a time when many college students are dropping out to join AI startups, one former MIT student says she called it quits because she's afraid of something altogether more catastrophic: that an artificial general intelligence (AGI), or superhuman AI, will completely wipe out the human race, Forbes reports. "I was concerned I might not be alive to graduate because of AGI," Alice Blair, who enrolled at the university in 2023, told the publication. "I think in a large majority of the scenarios, because of the way we are working towards AGI, we get human extinction." Blair now works as a technical writer at the nonprofit Center for AI Safety, and has no plans to go back to MIT. She joined, hoping to meet other people interested in making AI safe, and apparently was disappointed. "I predict that my future lies out in the real world," she told Forbes. Nikola Jurković, a Harvard alum who served at his school's AI safety club, is sympathetic to the idea. "If your career is about to be automated by the end of the decade, then every year spent in college is one year subtracted from your short career," he told Forbes. "I personally think AGI is maybe four years away and full automation of the economy is maybe five or six years away." Building an AGI, a system that matches or surpasses human intelligence, is much of the AI industry's endgame. OpenAI CEO Sam Altman called the recent launch of its poorly-received AI model GPT-5 a major stepping stone towards AGI, even going as far as to call it "generally intelligent." Many experts are skeptical, however, that we're anywhere near building such a powerful AI model, and point to recent signs that improvements to the tech are hitting a wall. "It is extremely unlikely that AGI will come in the next five years," Gary Marcus, an AI researcher and outspoken critic of the industry, told Forbes. "It's just marketing hype to pretend otherwise when so many core problems (like hallucinations and reasoning errors) remain unsolved." And while there are very real forms of harm that AI can cause, outright extinction is a little far-fetched, Marcus said. In fact, the AI industry probably wants you to buy into AI doomsday prophesying. Altman and other tech CEOs raise these risks themselves. Doing so creates the impression that the tech is far more capable than it currently is, and allows these companies to control the narrative around how the tech should be regulated. And if you're envisioning an apocalypse like in "The Matrix" movies — human enslavement at the hands of machine intelligences that rebelled against their creators — you may be ignoring the very mundane forms of harm it's already causing, like job automation and the gutting of the environment. More on AI: Sam Altman Calls His Own AI Model "Annoying" After Being Forced to Raise It From the Dead Solve the daily Crossword
CNET
10 hours ago
- CNET
Generative AI Gave MIT Scientists a New Tool to Fight Antibiotic-Resistant Bacteria
Antibiotic-resistant bacteria are dangerous because they already "know" what most antibiotics look like. Scientists at MIT have found a way to create something new: using generative AI to design two antibiotic compounds from scratch that can kill drug-resistant gonorrhea and MRSA in lab dishes and mice. Antibiotic resistance is one of the world's biggest public health threats yet new antibiotics have been scarce for decades. Traditional drug discovery methods rely on screening known chemical libraries -- a slow process with a limited pool of existing molecules to test. In contrast, MIT's AI system generated more than 36 million theoretical compounds, many with chemical structures never seen before, and zeroed in on two standouts. Both are unlike any antibiotic currently in use, offering a glimpse at how AI can move beyond speeding up research to imagine medicines that might have been impossible to find otherwise. "We wanted to get rid of anything that would look like an existing antibiotic, to help address the antimicrobial resistance crisis in a fundamentally different way," said Aarti Krishnan, MIT postdoc and one of the study's lead authors. "By venturing into underexplored areas of chemical space, our goal was to uncover novel mechanisms of action." Read also: Do You Really Learn When You Use AI? What MIT Researchers Found How the science was pulled off The MIT team bypassed the limitations of screening existing chemical libraries by asking AI to invent molecules from scratch, generating more than 36 million theoretical compounds, which were then narrowed down to a few to be tested against drug-resistant superbugs. This involved two AI-driven strategies: Fragment-based design: The AI began with a chemical fragment (labeled F1) that showed promise against gonorrhea. It produced millions of derivatives, ultimately refining a shortlist of about 1,000 candidates. Of the 80 chosen by researchers, NG1 emerged as a standout compound that successfully treated drug-resistant gonorrhea in cell cultures and a mouse. Unconstrained generation: The team let the AI roam freely, designing molecules on its own, aiming at MRSA. This produced more than 29 million candidates, which were filtered down to 90 compounds for synthesis. Twenty-two were produced, six performed well in lab tests and one in particular, DN1, proved able to eliminate MRSA skin infections in mice. NG1 and DN1 are structurally distinct from any currently known antibiotics and appear to destroy bacteria by disrupting their cell membranes. NG1 specifically targets LptA, a previously untapped bacterial protein involved in constructing the outer cell membrane. What's next for antibiotic research Phare Bio, a nonprofit in the Antibiotics-AI Project, is refining NG1 and DN1 to improve their drug properties, while researchers expand the AI platform to target other tough pathogens like Mycobacterium tuberculosis (the causative agent of tuberculosis) and Pseudomonas aeruginosa (a group of bacteria that often causes infections in health-care settings). The study, first published in the journal Cell, signals a hopeful turn in the global struggle against superbugs. However, these findings are early-stage. Initial tests and lab results are encouraging, but human safety and efficacy must be established through rigorous lab refinement and clinical trials, a process that could span several years. This effort builds on MIT's previous breakthroughs in AI-guided antibiotic development, including halicin, discovered in 2020 via deep learning, and abaucin, discovered in 2023 via a machine-learning algorithm. Read more: AI Essentials: 29 Ways to Make Gen AI Work for You, According to Our Experts
Yahoo
a day ago
- Yahoo
Rivian's CEO explains why he got a Ph.D. — and why he chose MIT over Stanford
Rivian CEO RJ Scaringe said that his Ph.D. from MIT gave him "credibility" when approaching investors. Scaringe told the "Tosh Show" that he went to Stanford for a day before switching over to MIT for their automotive program. "It was like being recruited for a nerd sports team," Scaringe said of choosing between MIT and Stanford. Some people pursue Ph.D.s to work in academia or to attain lofty research positions. The CEO of Rivian got his so people would take him seriously. RJ Scaringe founded Mainstream Motors — later renamed Rivian — in 2009. It took over a decade to collect capital, build manufacturing capabilities, and eventually distribute the company's first consumer electric vehicle, the R1T. When pitching his EV company to investors, Scaringe had a résumé perk: his Ph.D. from Massachusetts Institute of Technology. On the "Tosh Show," Scaringe said that he figured the degree would put him in good standing in investor rooms. "I thought, 'I'll need a lot of money. I don't have any money, and if I'm going to get other people to invest money into this thing that I want to build, me having a Ph.D. from MIT or equivalent makes that more likely,'" Scaringe said. Pitching a vehicle company is difficult, as Scaringe described on the podcast. Given the upfront capital costs to make a basic prototype, EV entrepreneurs like Scaringe are often pitching an idea more than a discreet product. Thus, EV founders need credibility — and Scaringe didn't want to wait decades. "I didn't want to go work at a car company for 20 years and earn credibility," he said. "So I wanted to get like credibility as quickly as I could." For Scaringe, that came in the form of a Ph.D. in automotive mechanical engineering. MIT is a hotbed for entrepreneurs. Notable Ph.D. alums include Intel cofounder Robert Noyce and Boston Dynamics founder Marc Raibert. Amar Bose of Bose Corporation got his Sc.D. from the institution. When picking his graduate institution, Scaringe had two options: MIT or Stanford University. Having graduated first in his class at Rensselaer Polytechnic Institute, Scaringe said he had plenty of options and was being courted by various programs. "It was like being recruited for a nerd sports team because MIT offered me this amazing role, Stanford offered me this amazing role," he said. Scaringe accepted his offer from Stanford and enrolled for a day before switching over to MIT. "I actually preferred the program at MIT," Scaringe said. "The reason I really liked what MIT had is that they had an automotive-specific program and a lab built around automotive, and I knew I wanted to start what eventually became Rivian." Scaringe called his reasoning for getting a Ph.D. "wonderfully naive" — but "it worked." Read the original article on Business Insider Sign in to access your portfolio
